ASX - By Stock
|
RHY |
Re:
Upcoming Event in Chicago
|
|
dazby
|
28 |
7.3K |
2 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
28
|
7.3K
|
2
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
dazby
|
80 |
45K |
4 |
28/01/23 |
28/01/23 |
Charts
|
80
|
45K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of Director's Interest Notice
|
|
dazby
|
16 |
6.9K |
3 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
16
|
6.9K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Investor Roadshows
|
|
dazby
|
17 |
7.6K |
4 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
17
|
7.6K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK
|
|
dazby
|
42 |
18K |
3 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
42
|
18K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK
|
|
dazby
|
42 |
18K |
2 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
42
|
18K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Presentation
|
|
dazby
|
11 |
8.0K |
2 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
11
|
8.0K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Presentation
|
|
dazby
|
11 |
8.0K |
1 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
11
|
8.0K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Another Device Sold/Used in Madrid
|
|
dazby
|
7 |
3.1K |
0 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Another Device Sold/Used in Madrid
|
|
dazby
|
7 |
3.1K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Another Device Sold/Used in Madrid
|
|
dazby
|
7 |
3.1K |
1 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Trading Halt
|
|
dazby
|
14 |
7.6K |
2 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
14
|
7.6K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Commerical Pancreas Treatment In Spain
|
|
dazby
|
44 |
20K |
6 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
44
|
20K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Presentation
|
|
dazby
|
36 |
16K |
11 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
36
|
16K
|
11
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dazby
|
16 |
11K |
0 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
16
|
11K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
dazby
|
66 |
18K |
2 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
66
|
18K
|
2
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Change of Director's Interest Notice
|
|
dazby
|
1 |
742 |
3 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
1
|
742
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
dazby
|
66 |
18K |
6 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
66
|
18K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
dazby
|
4 |
1.6K |
7 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
4
|
1.6K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
dazby
|
9 |
5.7K |
3 |
01/10/21 |
01/10/21 |
ASX - By Stock
|
9
|
5.7K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue
|
|
dazby
|
10 |
4.0K |
3 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
10
|
4.0K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Initial TGA Regulatory Documentation Submitted
|
|
dazby
|
19 |
7.3K |
11 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
19
|
7.3K
|
11
|
|
ASX - By Stock
|
RHY |
Re:
Ann: No Extension to Rights Issue Offer Closing Date
|
|
dazby
|
5 |
2.7K |
3 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
5
|
2.7K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Bell Potter what gives?
|
|
dazby
|
27 |
17K |
0 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
27
|
17K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Initial TGA Regulatory Documentation Submitted
|
|
dazby
|
19 |
7.3K |
1 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
19
|
7.3K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Initial TGA Regulatory Documentation Submitted
|
|
dazby
|
19 |
7.3K |
2 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
19
|
7.3K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Bell Potter what gives?
|
|
dazby
|
27 |
17K |
1 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
27
|
17K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Bell Potter what gives?
|
|
dazby
|
27 |
17K |
4 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
27
|
17K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Non Renounceable pro rata offer - Completion of despatch
|
|
dazby
|
14 |
3.9K |
2 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
14
|
3.9K
|
2
|
|
ASX - By Stock
|
WEL |
Re:
Ann: Becoming a substantial holder from HE8
|
|
dazby
|
6 |
1.9K |
6 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
6
|
1.9K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4D and Half Yearly Report and Accounts
|
|
dazby
|
4 |
4.1K |
4 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
4
|
4.1K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Business Update - Conference Call Notification
|
|
dazby
|
2 |
1.8K |
0 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
2
|
1.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
dazby
|
12 |
6.0K |
3 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
12
|
6.0K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation - December 2020
|
|
dazby
|
61 |
25K |
4 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
61
|
25K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation - December 2020
|
|
dazby
|
61 |
25K |
6 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
61
|
25K
|
6
|
|
ASX - By Stock
|
XAM |
Re:
Ann: Copper-Gold Mineralisation Expands at Kharmagtai
|
|
dazby
|
51 |
14K |
2 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
51
|
14K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Cancellation of shares under the Employee Share Plan
|
|
dazby
|
5 |
4.2K |
6 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
5
|
4.2K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Cancellation of shares under the Employee Share Plan
|
|
dazby
|
5 |
4.2K |
2 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
5
|
4.2K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
dazby
|
64 |
43K |
0 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
64
|
43K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
dazby
|
64 |
43K |
4 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
64
|
43K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
dazby
|
64 |
43K |
2 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
64
|
43K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
dazby
|
64 |
43K |
3 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
64
|
43K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
dazby
|
64 |
43K |
3 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
64
|
43K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
dazby
|
64 |
43K |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
64
|
43K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil receives Swiss regulatory approval
|
|
dazby
|
61 |
27K |
0 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
61
|
27K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
AGM VOTE
|
|
dazby
|
7 |
2.6K |
5 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
7
|
2.6K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Placement & Rights Offer to raise approximately $6 million
|
|
dazby
|
63 |
18K |
0 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
63
|
18K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
dazby
|
126 |
49K |
0 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
126
|
49K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Oncosil breakthrough device receives CE Marking approval
|
|
dazby
|
165 |
67K |
1 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
165
|
67K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Oncosil breakthrough device receives CE Marking approval
|
|
dazby
|
165 |
67K |
0 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
165
|
67K
|
0
|
|